Literature DB >> 12401695

The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.

G Jerusalem1, R Hustinx, Y Beguin, G Fillet.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12401695     DOI: 10.1093/annonc/mdf664

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  PET functional volume delineation: a robustness and repeatability study.

Authors:  Mathieu Hatt; Catherine Cheze Le Rest; Nidal Albarghach; Olivier Pradier; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

2.  Adaptive region-growing with maximum curvature strategy for tumor segmentation in 18F-FDG PET.

Authors:  Shan Tan; Laquan Li; Wookjin Choi; Min Kyu Kang; Warren D D'Souza; Wei Lu
Journal:  Phys Med Biol       Date:  2017-06-12       Impact factor: 3.609

Review 3.  The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials.

Authors:  Stephane Chauvie; Fabrizio Bergesio
Journal:  Biomedicines       Date:  2016-11-15

4.  Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation.

Authors:  Julien Ganem; Sebastien Thureau; Pierrick Gouel; Bernard Dubray; Mathieu Salaun; Edgar Texte; Pierre Vera
Journal:  PLoS One       Date:  2019-10-11       Impact factor: 3.240

5.  Selectively recommend 18F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas.

Authors:  Chuanben Chen; Ting Xu; Xiufang Qiu; Shihan Xie; Ziqing You; Yixin Hu; Yinghong Zheng; Zewei Liang; Chaoxiong Huang; Taojun Chen; Li Li; Jing Liu; Zhaodong Fei
Journal:  Radiat Oncol       Date:  2021-11-27       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.